Issuing stock options requires rigorous process management. Founders must get formal board approval for every grant, maintain a current 409A valuation to set the strike price, use the correct type of option (ISO vs. NSO), and ensure all grant documents are signed. Proactively managing your option pool and standardizing vesting schedules will prevent major headaches during fundraising or an exit.
Key takeaways
- Always get board approval for every stock option grant.
- Maintain a valid 409A valuation, refreshing it annually and after any material event.
- Use ISOs for US employees and NSOs for contractors and international team members.
- Standardize your grant process: board consent, grant agreement, and cap table software.
- Manage your option pool like a budget; don’t grant more shares than you have reserved.
- Use a 4-year vesting schedule with a 1-year cliff as your default for all new hires.
Stock options are a promise. You offer a piece of the future upside in exchange for an employee’s talent and commitment. Get it right, and you create a team of owners. Get it wrong, and you turn that promise into a liability that can cost you key hires, create tax penalties, and kill a funding round during due diligence.
This isn’t about polished paperwork; it’s about the core mechanics of granting equity. Avoid these common mistakes.
Mistake 1: Not Getting Formal Board Approval
You promise a new hire 10,000 options in their offer letter. They sign. The grant is official, right? Wrong. Stock options only exist if they are formally approved by your company’s board of directors.
The Damage
Without a board resolution, the options were never legally granted. This becomes a crisis during fundraising or M&A diligence. An investor’s lawyers will find every instance where an offer letter promised options that weren’t backed by a board consent. It signals carelessness and forces you into a messy cleanup, which could involve re-pricing grants at a higher value and creating tax problems for your employees.
The Fix: Document Everything
Use precise language in offer letters. Your offer letter should only state the intent to recommend a grant. Use this language: “Subject to approval by the Company’s Board of Directors, you will be recommended for a grant of an option to purchase [Number] shares of the Company’s common stock.” · Use Unanimous Written Consent (UWC). You don’t need a formal meeting for every grant. Have your lawyer create a UWC template you can circulate to the board for email signatures. · Ensure your board consent is specific. It must include the grantee’s name, their relationship (employee, advisor), the number of shares, the type of option (ISO or NSO), the vesting schedule, and the exercise price (strike price), which must match or exceed your current 409A valuation.
Mistake 2: Failing to Get or Maintain a 409A Valuation
You’re an early-stage company, so you pick a strike price that feels right—say, $0.05 per share. But the IRS requires that options be priced at or above Fair Market Value (FMV), and they don’t care what you “feel” it should be.
The Damage
If the IRS determines your strike price was below FMV, the grant is subject to harsh 409A penalties. This primarily hurts your employee, who will face back taxes and a 20% federal penalty. It makes your equity toxic and shows investors that you aren’t managing the company professionally.
The Fix: Follow a Strict 409A Cadence
An independent 409A valuation from a third-party firm provides a “safe harbor,” protecting you from penalties.
Get one before your first grant. No exceptions. A typical 409A for a seed-stage company costs $2,000 - $6,000. · Refresh it every 12 months. A 409A valuation is only valid for one year. Set a calendar reminder. · Refresh it after any “material event.” This includes: raising a priced round of financing, signing a term sheet for one, a significant secondary sale of stock, or a dramatic change in your financial trajectory (e.g., landing a massive contract).
Non-Obvious Tip: Granting options right before a new funding round closes is a powerful move. It allows you to grant at the lower, pre-money 409A valuation. Wait until after the round closes, and the new 409A will be significantly higher, making subsequent grants less valuable to employees.
Mistake 3: Misunderstanding ISOs vs. NSOs
You grant the same type of options to your lead engineer in California and your marketing contractor in Portugal. This can create an unnecessary tax burden and compliance headache.
The Damage
Granting ISOs to non-employees is a compliance violation. More subtly, not understanding the practical tax differences can lead you to over-sell a benefit that may never materialize for your team.
Incentive Stock Options (ISOs): For employees only (in the US). They offer favorable tax treatment—if the employee exercises and holds the stock for over a year (and two years from the grant date), the entire gain is taxed as long-term capital gains. However, there's a major catch: exercising a large number of ISOs can trigger the Alternative Minimum Tax (AMT), a tax bill on the "paper gain" that the employee must pay with real cash, even if they can't sell the stock. · Non-Qualified Stock Options (NSOs): For anyone (employees, contractors, advisors). When exercised, the spread between the strike price and the current FMV is taxed as ordinary income. It’s simple and predictable.
The Fix: Use the Right Option for the Right Person
Use ISOs for US employees, as they provide a potential tax benefit. Use NSOs for contractors, advisors, and all international team members.
However, many sophisticated startups are defaulting to NSOs for all grants, even to US employees. Why? The "tax benefit" of an ISO is often theoretical. Early employees rarely have the cash to exercise their options and hold them for a year to get the long-term capital gains treatment. The simplicity and predictability of NSOs are often better for everyone.
Mistake 4: Over-Granting from Your Option Pool
You’re hiring fast and grant a few key hires 1% each. The problem? You only had 1.5% left in your board-approved employee option pool. You have now promised shares that don’t exist.
The Damage
This is a serious error that creates a legal and administrative nightmare. To fix it, you must get board and investor approval to increase the option pool, which dilutes all existing shareholders—including you. It looks amateurish and forces a painful conversation with your investors.
The Fix: Manage Your Pool Like a Budget
Size it correctly. A typical seed-stage option pool is 10-15% of the company’s fully-diluted shares. · Track it religiously. Use cap table software like Carta or Pulley as your single source of truth. Before making an offer, check the pool balance. · Understand the Series A "Shuffle." When you raise your Series A, investors will require you to increase the option pool to ~10-12% of the post-money capitalization. Critically, they will insist this dilution comes out of the pre-money valuation, diluting only founders and existing employees. This is a standard term. Plan for it by not over-granting in your seed stage.
Let’s say you agree to a $10M pre-money valuation for your $4M Series A. The investors require a new 10% option pool on a post-money basis ($14M post-money = $1.4M pool).
Instead of valuing your company at $10M, they will calculate their ownership against an "effective" pre-money of $8.6M ($10M - $1.4M). You and your existing team absorb the full 10% dilution, while the new investors do not. Be ready for this math.
Mistake 5: Not Standardizing Vesting and Paperwork
An early employee quits two years in. You go to your spreadsheet to figure out their vesting and realize it was a custom schedule, the start date is ambiguous, and you never got their signed grant agreement.
The Damage
Ownership is the bedrock of a startup. Ambiguity here is cancer. Without a clear, signed record, you don’t know who owns what. This will halt a diligence process dead in its tracks until your lawyers can clean it up.
The Fix: Automate and Standardize from Day One
Use cap table software. Non-negotiable. Excel is not a cap table. From your first grant, use a platform like Carta or Pulley to issue, sign, and track all equity. The $2k-$5k annual cost is insurance against million-dollar mistakes. · Standardize your grants. A complete grant package includes: (1) The company’s Stock Incentive Plan, (2) the signed Board Consent, and (3) the individual Stock Option Agreement, signed by the employee. Your software platform handles this automatically. · Use a standard vesting schedule. The universal standard is a 4-year vesting period with a 1-year "cliff." This means the employee receives no options until their first anniversary, at which point 25% of their grant vests. The remainder vests monthly for the next three years. Custom schedules create complexity you don’t need. (The only exception is for advisors, who typically vest over 1-2 years). · Set the Vesting Commencement Date (VCD) to their start date. Even if the board approves the grant a few weeks later, the vesting clock should begin when they did. This aligns ownership with tenure.
A Final, Critical Detail: The Post-Termination Exercise Period (PTEP)
Most stock plans give employees only 90 days to exercise their vested options after they leave the company. This is a huge problem. An employee might have $50,000 in vested options but needs to come up with $10,000 in cash to exercise them—cash they likely don’t have. The result? They walk away with nothing.
This creates "golden handcuffs" and a sense of unfairness. Progressive companies are fixing this by extending the PTEP to 2, 5, or even 10 years. Extending the PTEP beyond 90 days causes an ISO to convert into an NSO, but this is a worthwhile trade-off for employee fairness.
How to Apply This This Week
Don't wait for a funding round to discover these problems. Take these steps now:
Audit Your Grants. Log into your cap table software. For every single grant, confirm there is a corresponding signed board consent and a signed grant agreement from the employee. If you find gaps, email your lawyer today to get them ratified. · Check Your 409A Date. When was your last 409A valuation performed? If it was more than 10 months ago, or if you’ve raised capital or hit a major milestone since, order a refresh now. · Model Your Option Pool. Open a spreadsheet and build a simple hiring plan for the next 12 months. Assign equity levels to each role. Do you have enough shares in your pool to cover it? · Review Your PTEP. What does your stock plan say about the post-termination exercise period? If it’s the default 90 days, have a conversation with your co-founders and board about whether a more employee-friendly policy makes sense. · Create a Grant Checklist. Create a simple, mandatory checklist for every new grant: 1) Offer letter sent with correct language. 2) 409A is valid. 3) Board consent drafted and signed by all board members. 4) Grant issued via cap table software. 5) Confirm employee has signed the agreement.
Handling stock options correctly is a direct signal of your quality as an operator. It proves to investors you are professional and demonstrates to your team that their ownership is real.
Frequently asked questions
- How much does a 409A valuation cost?
- For an early-stage startup, a 409A valuation typically costs between $2,000 and $6,000. The price depends on the complexity of your business and the firm you use.
- How big should our employee option pool be?
- A seed-stage option pool is typically 10-15% of the company. When you raise a Series A, investors will expect you to refresh the pool to 10-12% of the post-money capitalization to cover hiring for the next 18-24 months.
- What's the difference between an ISO and an NSO?
- Incentive Stock Options (ISOs) offer potential tax advantages but can only be granted to US employees. Non-Qualified Stock Options (NSOs) can be granted to anyone (employees, contractors, advisors) and are simpler, with income tax due at exercise.
- What happens if we made a mistake on a past grant?
- Contact your lawyers immediately. They can typically help you 'ratify' the grant with a corrective board resolution, cleaning up the paper trail before it becomes a major problem during investor due diligence.